Gengenbacher D, Keyhani A, Engel H, Sanchez-Williams G, Champlin R, Andreeff M
A new survey report from the International Foundation of Employee Benefit Plans reveals results from a group of Canadian employers regarding considerations and coverage for glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes and are increasingly being used to treat obesity
Following 24 hours of saline or liraglutide treatment, islets were washed with culture media containing 16.1 mM glucose for 1 hour, after which islets were washed with PBS
For medical advice about side effects, talk with your health care professional
Strinic, Over-Dose Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157
Zoeller, EDC-2: The Endocrine Societys Second Scientific Statement on Endocrine-Disrupting Chemicals